<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:News="http://www.bing.com/news/search?q=clinical&amp;format=rss"><channel><title>clinical - BingNews</title><link>http://www.bing.com/news/search?q=clinical&amp;format=rss</link><description>Search results</description><image><url>http://www.bing.com/rsslogo.gif</url><title>clinical</title><link>http://www.bing.com/news/search?q=clinical&amp;format=rss</link></image><copyright>Copyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><item><title>Nurse-Built AI Clinical Agent Targets $177M in Improper Medicare Wound-Care Payments</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a152329691240ad850fdeba71c796c4&amp;url=https%3a%2f%2fwww.tennessean.com%2fpress-release%2fstory%2f185206%2fnurse-built-ai-clinical-agent-targets-177m-in-improper-medicare-wound-care-payments%2f&amp;c=4053531388488249652&amp;mkt=en-us</link><description>First AI clinical agent built exclusively for wound care; expanding specialist-level care to rural America, U.S.</description><pubDate>Mon, 25 May 2026 05:15:00 GMT</pubDate><News:Source>The Tennessean</News:Source></item><item><title>Fixing Medication Adherence In Clinical Trials: How Technology Stops Data Corruption</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a152329691240ad850fdeba71c796c4&amp;url=https%3a%2f%2fwww.forbes.com%2fsites%2fforbesbooksauthors%2f2026%2f05%2f21%2ffixing-medication-adherence-in-clinical-trials-how-technology-stops-data-corruption%2f&amp;c=1866214178761074103&amp;mkt=en-us</link><description>Medication adherence in clinical trials is hard to verify, but new technologies are fixing that. Discover why traditional methods fail and how cutting-edge tools are improving compliance monitoring.</description><pubDate>Thu, 21 May 2026 07:03:00 GMT</pubDate><News:Source>Forbes</News:Source><News:Image>http://www.bing.com/th?id=ONUT.j-pyyXYaS4KjoTtLaA_e6g&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1349</News:ImageMaxWidth><News:ImageMaxHeight>900</News:ImageMaxHeight></item><item><title>Retatrutide, Eli Lilly's next obesity drug, fueled dramatic weight loss in clinical trial</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a152329691240ad850fdeba71c796c4&amp;url=https%3a%2f%2fwww.fox10phoenix.com%2fnews%2fretatrutide-eli-lillys-trial-results&amp;c=13543783098152954787&amp;mkt=en-us</link><description>Clinical trial results for retatrutide, Eli Lilly’s next weight loss drug, showed far more weight loss than other blockbuster obesity drugs.</description><pubDate>Thu, 21 May 2026 10:40:00 GMT</pubDate><News:Source>FOX 10 Phoenix</News:Source><News:Image>http://www.bing.com/th?id=ONUT.hXtQIcTkoVlxKy8_6L-PVw&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1200</News:ImageMaxWidth><News:ImageMaxHeight>630</News:ImageMaxHeight></item><item><title>Caliway secures FDA clearance for CBL-514 clinical trial</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a152329691240ad850fdeba71c796c4&amp;url=https%3a%2f%2fwww.msn.com%2fen-us%2fhealth%2fother%2fcaliway-secures-fda-clearance-for-cbl-514-clinical-trial%2far-AA241TPh&amp;c=4723765524931646034&amp;mkt=en-us</link><description>Caliway intends to commence both pivotal Phase III trials soon, with clinical results for CBL-0301 and CBL-0302 expected in 2027.</description><pubDate>Mon, 25 May 2026 03:37:05 GMT</pubDate><News:Source>Clinical Trials Arena on MSN</News:Source><News:Image>http://www.bing.com/th?id=ONUT.ZLLS4LoUyqvsGehMiJBfLQ&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1440</News:ImageMaxWidth><News:ImageMaxHeight>810</News:ImageMaxHeight></item><item><title>Backed by science: Indulekha Bringha hair growth serum completes second clinical trial, proves new hair growth in 90 days</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a152329691240ad850fdeba71c796c4&amp;url=https%3a%2f%2fwww.msn.com%2fen-in%2fhealth%2fother%2fbacked-by-science-indulekha-bringha-hair-growth-serum-completes-second-clinical-trial-proves-new-hair-growth-in-90-days%2far-AA23ZkNY&amp;c=3419275363222245269&amp;mkt=en-us</link><description>Press Release | The findings indicate that the formulation supports the natural hair growth cycle by delivering results at a follicular level.</description><pubDate>Sun, 24 May 2026 22:50:16 GMT</pubDate><News:Source>India Today on MSN</News:Source><News:Image>http://www.bing.com/th?id=ONUT.4_zVGsJLjXWDfzVy4f2mRw&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1200</News:ImageMaxWidth><News:ImageMaxHeight>675</News:ImageMaxHeight></item><item><title>Kordata Launches To Advance Neurotech-Powered Clinical Trials</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a152329691240ad850fdeba71c796c4&amp;url=https%3a%2f%2fwww.forbes.com%2fsites%2fnaveenrao%2f2026%2f05%2f21%2fkordata-launches-to-advance-neurotech-powered-clinical-trials%2f&amp;c=5981936968764456961&amp;mkt=en-us</link><description>Kordata, a BIOS Ltd spinout, will advance next-generation clinical trial sites powered with neural recording technologies and enterprise b2b capabilities.</description><pubDate>Thu, 21 May 2026 09:06:00 GMT</pubDate><News:Source>Forbes</News:Source><News:Image>http://www.bing.com/th?id=ONUT.WLi-QiQIw1U3a_LaPoP43g&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1350</News:ImageMaxWidth><News:ImageMaxHeight>900</News:ImageMaxHeight></item><item><title>Betting on biotech: Prediction markets set sights on clinical trials</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a152329691240ad850fdeba71c796c4&amp;url=https%3a%2f%2fwww.fiercebiotech.com%2fbiotech%2fbetting-biotech-prediction-markets-set-sights-clinical-trials&amp;c=3671062598599603925&amp;mkt=en-us</link><description>One day in early May, web-based prediction market platform Kalshi listed two contracts tied to Compass Pathways’ psilocybin drug, COMP360. | Several biotech contracts are rotating through Kalshi and ...</description><pubDate>Thu, 21 May 2026 07:30:00 GMT</pubDate><News:Source>Fierce Biotech</News:Source><News:Image>http://www.bing.com/th?id=ONUT.OtpwFnmNHe_be6yUAAx7Uw&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>8256</News:ImageMaxWidth><News:ImageMaxHeight>4644</News:ImageMaxHeight></item><item><title>Lawmakers, health leaders make bipartisan push to expand clinical trials access</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a152329691240ad850fdeba71c796c4&amp;url=https%3a%2f%2fwww.aol.com%2fnews%2flawmakers-health-leaders-bipartisan-push-222645068.html&amp;c=12144031577057215911&amp;mkt=en-us</link><description>A House Democrat and Republican on Wednesday highlighted their push to expand access to clinical trials, saying artificial intelligence could be one tool used to reach more underrepresented ...</description><pubDate>Wed, 20 May 2026 22:26:00 GMT</pubDate><News:Source>AOL</News:Source><News:Image>http://www.bing.com/th?id=ONUT.HvpS_V_per0xXkXw71YCGQ&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>900</News:ImageMaxWidth><News:ImageMaxHeight>505</News:ImageMaxHeight></item><item><title>Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a152329691240ad850fdeba71c796c4&amp;url=https%3a%2f%2fwww.rutlandherald.com%2fnews%2fbusiness%2fbaszucki-group-funds-oxford-university-clinical-trial-of-ketogenic-therapy-for-early-psychosis%2farticle_7b52919b-d429-51a2-a6d2-04ba77e98928.html&amp;c=13942933311260097376&amp;mkt=en-us</link><description>Baszucki Group today announced a &#163;1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for ...</description><pubDate>Thu, 21 May 2026 03:02:00 GMT</pubDate><News:Source>Rutland Herald</News:Source><News:Image>http://www.bing.com/th?id=ONUT.JPeD5Vug_z7Wn0SsPNTKtw&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1200</News:ImageMaxWidth><News:ImageMaxHeight>630</News:ImageMaxHeight></item><item><title>1 in 10 surgeons leave clinical practice within 8 years: Report</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a152329691240ad850fdeba71c796c4&amp;url=https%3a%2f%2fwww.beckershospitalreview.com%2fquality%2fhospital-physician-relationships%2f1-in-10-surgeons-leave-clinical-practice-within-8-years-report%2f&amp;c=17180525050709795865&amp;mkt=en-us</link><description>Surgeons leave clinical practice at higher rates mid-career, with a 9.7% attrition over eight years, reveals a national study by Ohio State University.</description><pubDate>Thu, 21 May 2026 12:37:00 GMT</pubDate><News:Source>Becker's Hospital Review</News:Source></item><item><title>Clinical Psychologist Says Wives Who Can Never Admit They're Wrong Have One Thing In Common</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a152329691240ad850fdeba71c796c4&amp;url=https%3a%2f%2fwww.yourtango.com%2flove%2fclinical-psychologist-says-wives-cant-admit-wrong-have-one-thing-common&amp;c=18150921969425638508&amp;mkt=en-us</link><description>Many husbands experience the frustration of a wife who never admits she's wrong, and clinical psychologist Dr. Samantha Rodman Whiten says it almost never has to do with stubbornness or ego.</description><pubDate>Sat, 23 May 2026 05:05:00 GMT</pubDate><News:Source>YourTango</News:Source><News:Image>http://www.bing.com/th?id=ONUT.IewDDQEAh2Sp07ngeovZ7g&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1280</News:ImageMaxWidth><News:ImageMaxHeight>720</News:ImageMaxHeight></item></channel></rss>